» Articles » PMID: 1079460

[Lymphocyte in Chronic Lymphatic Leukemia]

Overview
Journal Blut
Specialty Hematology
Date 1975 May 1
PMID 1079460
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with chronic lymphatic leukemia (CLL) the majority of peripheral blood lymphocytes was characterized as B cells by surface membrane markers. Ultrastructural studies revealed a reduction of the cytoplasmic area. Furthermore, the number of lysosomes was diminished corresponding to a decreased activity of lysosomal hydrolases. Increasing blood lymphocytosis was paralleled by an increase of the percentage of lysosome-poor lymphocytes. Response of CLL lymphocytes to in vitro stimulation with PHA and PWM was either lacking or diminished and/or delayed, and the number of transformed cells was reduced. Thus, the majority of CLL lymphocytes appears to represent both morphologically and functionally abnormal neoplastic b cells. During the early and later phase of stimulation the mitogen-reactive CLL lymphocytes exhibited alterations of the lysosomal apparatus similar to those observed in normal cells. The reactive lymphocytes may be derived from residual populations of normally functioning T and/or B cells. However, the neoplastic cells may also be able to respond to the mitogens. In vivo studies showed impaired kinetics of circulation and recirculation of CLL B lymphocytes, whereas the T cells were normal in this respect.

Citing Articles

Lipid composition of human lymphocytes in patients with chronic lymphatic leukaemia and with blocked T cell activity.

Smyth H, Corrigan A, OKennedy R Ir J Med Sci. 2016; 148(1):303.

PMID: 27517442 DOI: 10.1007/BF02938104.


[Chronic lymphatic leukemia of B-cell type: clinical and morphological investigations for diagnostic differentiation (author's transl)].

Schwarzmeier J, Radaszkiewicz T, Graninger W, Hofer F, Paietta E, Moser C Klin Wochenschr. 1981; 59(23):1313-8.

PMID: 6975856 DOI: 10.1007/BF01711181.


PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.

Robert K Clin Exp Immunol. 1979; 37(3):517-22.

PMID: 315847 PMC: 1537779.


B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.

Robert K, Moller E, Gahrton G, Eriksson H, Nilsson B Clin Exp Immunol. 1978; 33(2):302-8.

PMID: 309812 PMC: 1537573.

References
1.
Hirschhorn R, Brittinger G, Hirschhorn K, Weissmann G . Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J Cell Biol. 1968; 37(2):412-23. PMC: 2107423. DOI: 10.1083/jcb.37.2.412. View

2.
Catovsky D, TRIPP E, Hoffbrand A, Konig E, Cohnen G, Brittinger G . Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemia. Lancet. 1972; 1(7754):794-6. View

3.
Brittinger G, Konig E, Cohnen G, Aberle H . [Lysosomal enzymes in lymphocytes. I. Lymphoreticular diseases: comparison of the enzyme content (acid phosphatase, beta-glucuronidase) in unstimulated lymphocytes with blastic transformation after stimulation with phytohemagglutinin...]. Acta Haematol. 1970; 44(4):205-21. DOI: 10.1159/000208682. View

4.
Grey H, Rabellino E, PIROFSKY B . Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest. 1971; 50(11):2368-75. PMC: 292179. DOI: 10.1172/JCI106735. View

5.
Cohnen G, Douglas S, Konig E, Brittinger G . Acid phosphatase cytochemistry of mitrogen-transformed normal and chronic lymphocytic leukemia lymphocytes. Exp Cell Res. 1973; 80(2):297-304. DOI: 10.1016/0014-4827(73)90300-5. View